functional medicine near me

Agios Pharmaceuticals, Inc. (AGIO) Q4 2022 Earnings Call Transcript | Seeking Alpha Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ET Company Participants Jessi Rennekamp - Senior Director, Corporate Communications Brian Goff - CEO Sarah Gheuens - CMO & Head, R&D Tsveta Milanova - CCO Cecilia Jones - CFO Conference Call Participants Chris Raymond - Piper Sandler Marc Frahm - Cowen Mary Kate - Bank of America Tessa Romero - J.P. Morgan Greg Renza - RBC Mark Breidenbach - Oppenheimer Danielle Brill - Raymond James Operator Good morning, and welcome to Agios Fourth Quarter and Year-End 2022 Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Agios request. I would now like to turn the call over to Jessi Rennekamp, Senior Director of Corporate Communications. Please go ahead. Jessi Rennekamp Thank ...

ADC Therapeutics SA (ADCT) Q4 2022 Earnings Call Transcript | Seeking Alpha ADC Therapeutics SA (NYSE:ADCT) Q4 2022 Results Conference Call February 28, 2023 8:30 AM ET Company Participants Amanda Hamilton - IR Manager Ameet Mallik - CEO Kristen Harrington-Smith - Chief Commercial Officer Mohamed Zaki - Chief Medical Officer Pepe Carmona - Chief Financial Officer Conference Call Participants Kelly Shi - Jefferies Sudan N. Loganathan - RBC Naureen Quibria - Capital One Securities Brian Cheng - JPMorgan Operator Welcome to the ADC Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Andrew, and I'll be your operator for today's call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] I will now turn the call over to Amanda Loshbaugh, Investor Relations Manager. Amanda, you may begin. Amanda Hamilton Thank you, operator. This morning, we issued a press release...

3D-printed organs may soon be a reality | Fortune Well Last year, in San Antonio, Texas, Dr. Arturo Bonilla carefully implanted an outer ear on a 20-year-old woman born without one. The ear on the woman’s right side, had been constructed in the size and shape of her left. For Bonilla, a pediatric microtia surgeon (a doctor who treats birth defects of the ear) for more than 25 years and a recognized expert in the field, such a procedure would normally be routine. But this case had a twist: For the first time, the ear he was implanting was the product of a 3D bioprinter using the woman’s own cartilage cells. The implant procedure, Bonilla told me, was “very uneventful.” It is a vast understatement, all things considered. From the realm of near-fiction to the germ of an idea to actual science, 3D bioprinting is advancing across all aspects of medical research—and, now, practice. The pace is slow, and target dates for some of the most ambitious 3D plans are decades off. But progress is rea...